Amyloid cardiomyopathy associated with a novel apolipoprotein A–I Q172P variant

Frederick W. VonbergNational Amyloidosis Centre, Division of Medicine, University College London, London, UK and ;Oxford University Clinical Academic Graduate School, Oxford, UKCorrespondence[email protected] [email protected]

Janet A. GilbertsonNational Amyloidosis Centre, Division of Medicine, University College London, London, UK and

Dorota RowczenioNational Amyloidosis Centre, Division of Medicine, University College London, London, UK and

David F. HuttNational Amyloidosis Centre, Division of Medicine, University College London, London, UK and

Nigel RendellNational Amyloidosis Centre, Division of Medicine, University College London, London, UK and

Graham TaylorNational Amyloidosis Centre, Division of Medicine, University College London, London, UK and

Philip N. HawkinsNational Amyloidosis Centre, Division of Medicine, University College London, London, UK and

Julian D. GillmoreNational Amyloidosis Centre, Division of Medicine, University College London, London, UK and

show all

References

Rapezzi C, Quarta CC, Guidalotti PL, Longhi S, Pettinato C, Leone O, Ferlini A, et al. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy. Eur J Nucl Med Mol Imaging 2011;38:470–8
PubMed Web of Science ®Google Scholar
Rowczenio D, Dogan A, Theis JD, Vrana JA, Lachmann HJ, Wechalekar AD, Gilbertson JA, et al. Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A–I. Am J Pathol 2011;179:1978–87
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Amyloid cardiomyopathy associated with a novel apolipoprotein A–I Q172P variant

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Amyloid cardiomyopathy associated with a novel apolipoprotein A–I Q172P variant

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date